October 4, 2016
The Ministry of Health, Labor and Welfare (MHLW) has instructed Nagoya University to look into why recommended changes were not made to a paper on an investigator-initiated study led by the university involving Novartis Pharma’s hypertension drug Diovan (valsartan). The...read more